Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 72.83% institutional investors, 22.48% insiders, and 4.70% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.58% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.87% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals72.83%22.48%4.70%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.12M12.58%$227.15M
Blackrock5.94M12.33%$237.70M
Vanguard group2.71M5.58%$100.79M
Td asset management1.84M3.79%$68.33M
State street1.60M3.28%$59.26M
Neuberger berman group1.37M2.83%$51.02M
Pacer advisors1.35M2.78%$50.14M
Dimensional fund advisors lp1.20M2.47%$44.50M
Fuller & thaler asset management1.13M2.33%$42.07M
Epoch investment partners1.10M2.27%$40.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lam group130.80K3.46%$4.86M
Aurora investment counsel54.70K1.11%$2.03M
Mesirow institutional investment management380.39K1.09%$14.12M
Bridge city capital70.09K0.69%$2.60M
Granite investment partners396.70K0.64%$14.73M
Portolan capital management131.12K0.33%$4.87M
Oberweis asset management inc/184.59K0.32%$6.85M
Pdt partners90.48K0.30%$3.36M
Shaker investments llc/oh18.52K0.29%$687.65K
Boston trust walden978.92K0.26%$36.35M

Top Buyers

HolderShares% AssetsChange
Pacer advisors1.35M0.11%1.35M
Boston trust walden978.92K0.26%439.28K
Boston partners426.64K0.02%426.64K
Wealthfront advisers249.60K0.04%249.60K
Systematic financial management lp246.35K0.23%246.35K

Top Sellers

HolderShares% AssetsChange
Federated hermes823.49K0.07%-1.12M
Boone capital management---316.56K
Td asset management1.84M0.06%-294.75K
Neuberger berman group1.37M0.04%-240.96K
Portolan capital management131.12K0.33%-196.64K

New Positions

HolderShares% AssetsChangeValue
Boston partners426.64K0.02%426.64K$15.78M
Wealthfront advisers249.60K0.04%249.60K$14.12M
Systematic financial management lp246.35K0.23%246.35K$9.15M
Raymond james financial92.90K0.00%92.90K$3.45M
Aristeia capital43.23K0.05%43.23K$1.61M

Sold Out

HolderChange
Sjs investment consulting-1.00
Financial gravity asset management-1.00
Nelson, van denburg & campbell wealth management group-7.00
Capital performance advisors llp-11.00
Voisard asset management group-14.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024261-7.45%35,408,7620.08%721.38%116-18.31%1007.53%
Sep 30, 20242802.94%35,359,6972.73%721.47%140-93-4.12%
Jun 30, 2024268-1.83%34,405,3022.58%711.47%1382.99%96-1.03%
Mar 31, 2024273-2.85%33,540,0170.70%691.46%134-8.84%976.59%
Dec 31, 20232819.34%33,305,4864.00%691.60%14714.84%91-1.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.32M4.87%1.61K
Vanguard US Total Market Shares ETF1.14M2.40%1.24K
Vanguard Total Stock Mkt Idx Inv1.14M2.39%1.31K
FullerThaler Behavioral Sm-Cp Eq R61.08M2.27%-113.40K
FullerThaler Behavioral Small-Cap Equity1.08M2.27%-113.40K
iShares Russell 2000 ETF997.11K2.09%-8.63K
TD U.S. Capital Reinvestment I920.14K1.93%-27.55K
T. Rowe Price Integrated US SmCapGrEq850.11K1.77%425.06K
Neuberger Berman Genesis Inv794.66K1.65%-271.05K
Federated Hermes Kaufmann R615.00K1.26%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 01, 2025Petersen Floyd F.-Sell$14.19K
Mar 06, 2025Petersen Floyd F.-Sell$27.99K
Mar 04, 2025PETERS WILLIAM J CFO, EVP & TREASURERSell$116.52K
Dec 13, 2024Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$361.84K
Dec 12, 2024Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$310.98K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1-2
2024 Q4-7
2024 Q3-5
2024 Q2-6

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 72.83%, followed by 22.48% insiders and 4.69% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Amphastar Pharmaceuticals exceeds.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (6.12M shares, 12.58%), Blackrock (5.94M shares, 12.33%), and Vanguard group (2.71M shares, 5.58%). Together, they hold 30.49% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lam group is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.46% of its assets in 130.8K Amphastar Pharmaceuticals shares, valued at 4.86M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 4.87% of its total shares outstanding invested in 2.32M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools